Patents by Inventor John R. Neefe

John R. Neefe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human papilloma virus treatment
    Patent number: 7754449
    Abstract: Disclosed is a method of treating a wart in a subject by administering to the subject a composition containing (1) a heat shock protein or an immunostimulatory fragment thereof, and (2) a protein of a human papilloma virus or an antigenic fragment thereof. Also disclosed is a method of treating a human papilloma virus infection in a subject infected or suspected of being infected with a human papilloma virus of a first type by administering to the subject a composition containing (1) a heat shock protein or an antigenic fragment thereof, and (2) a protein of a human papilloma virus of a second type or an antigenic fragment thereof, where the first type and second type are different.
    Type: Grant
    Filed: April 26, 2007
    Date of Patent: July 13, 2010
    Assignee: Nventa Biopharmaceuticals Corporation
    Inventors: John R. Neefe, Stephen E. Goldstone, Mark T. Winnett, Marvin Siegel, Leslie J. Boux
  • Human papilloma virus treatment
    Patent number: 7211411
    Abstract: Disclosed is a method of treating a wart in a subject by administering to the subject a composition containing (1) a heat shock protein or an immunostimulatory fragment thereof, and (2) a protein of a human papilloma virus or an antigenic fragment thereof. Also disclosed is a method of treating a human papilloma virus infection in a subject infected or suspected of being infected with a human papilloma virus of a first type by administering to the subject a composition containing (1) a heat shock protein or an antigenic fragment thereof, and (2) a protein of a human papilloma virus of a second type or an antigenic fragment thereof, where the first type and second type are different.
    Type: Grant
    Filed: June 18, 2004
    Date of Patent: May 1, 2007
    Assignee: Nventa Biopharmaceuticals Corporation
    Inventors: John R. Neefe, Stephen E. Goldstone, Mark T. Winnett, Marvin Siegel, Leslie J. Boux
  • Human papilloma virus treatment
    Publication number: 20040235741
    Abstract: Disclosed is a method of treating a wart in a subject by administering to the subject a composition containing (1) a heat shock protein or an immunostimulatory fragment thereof, and (2) a protein of a human papilloma virus or an antigenic fragment thereof. Also disclosed is a method of treating a human papilloma virus infection in a subject infected or suspected of being infected with a human papilloma virus of a first type by administering to the subject a composition containing (1) a heat shock protein or an antigenic fragment thereof, and (2) a protein of a human papilloma virus of a second type or an antigenic fragment thereof, where the first type and second type are different.
    Type: Application
    Filed: June 18, 2004
    Publication date: November 25, 2004
    Applicant: Stressgen Biotechnologies Corporation, a Canadian corporation
    Inventors: John R. Neefe, Stephen E. Goldstone, Mark T. Winnett, Marvin Siegel, Leslie J. Boux
  • Human papilloma virus treatment
    Patent number: 6797491
    Abstract: Disclosed is a method of treating a wart in a subject by administering to the subject a composition containing (1) a heat shock protein or an immunostimulatory fragment thereof, and (2) a protein of a human papilloma virus or an antigenic fragment thereof. Also disclosed is a method of treating a human papilloma virus infection in a subject infected or suspected of being infected with a human papilloma virus of a first type by administering to the subject a composition containing (1) a heat shock protein or an antigenic fragment thereof, and (2) a protein of a human papilloma virus of a second type or an antigenic fragment thereof, where the first type and second type are different.
    Type: Grant
    Filed: February 13, 2003
    Date of Patent: September 28, 2004
    Assignee: Stressgen Biotechnologies Corporation
    Inventors: John R. Neefe, Stephen E. Goldstone, Mark T. Winnett, Marvin Siegel, Leslie J. Boux
  • Human papilloma virus treatment
    Publication number: 20030170268
    Abstract: Disclosed is a method of treating a wart in a subject by administering to the subject a composition containing (1) a heat shock protein or an immunostimulatory fragment thereof, and (2) a protein of a human papilloma virus or an antigenic fragment thereof. Also disclosed is a method of treating a human papilloma virus infection in a subject infected or suspected of being infected with a human papilloma virus of a first type by administering to the subject a composition containing (1) a heat shock protein or an antigenic fragment thereof, and (2) a protein of a human papilloma virus of a second type or an antigenic fragment thereof, where the first type and second type are different.
    Type: Application
    Filed: February 13, 2003
    Publication date: September 11, 2003
    Applicant: Stressgen Biotechnologies Corporation, a Canadian corporation
    Inventors: John R. Neefe, Stephen E. Goldstone, Mark T. Winnett, Marvin Siegel, Leslie J. Boux
  • Human papilloma virus treatment
    Publication number: 20020110566
    Abstract: Disclosed is a method of treating a wart in a subject by administering to the subject a composition containing (1) a heat shock protein or an immunostimulatory fragment thereof, and (2) a protein of a human papilloma virus or an antigenic fragment thereof. Also disclosed is a method of treating a human papilloma virus infection in a subject infected or suspected of being infected with a human papilloma virus of a first type by administering to the subject a composition containing (1) a heat shock protein or an antigenic fragment thereof, and (2) a protein of a human papilloma virus of a second type or an antigenic fragment thereof, where the first type and second type are different.
    Type: Application
    Filed: June 26, 2001
    Publication date: August 15, 2002
    Inventors: John R. Neefe, Stephen E. Goldstone, Mark T. Winnett, Marvin Siegel, Leslie J. Boux